Aclarion Inc (ACON) stock price

Aclarion Inc (ACON) is a Healthcare · Health Information Services company listed on NASDAQ. Price $2.63 (-0.38%), Market cap $0.01B, 52-week low–high $2.36 ~ $9.69.

Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCI

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Aclarion Inc are updated in real time on BlackAll Trade.

Aclarion Inc financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Aclarion Inc (ACON) stock price?

Aclarion Inc trades at $2.63 (-0.38%). Real-time quotes and charts are available on BlackAll Trade.

What is the Aclarion Inc (ACON) market cap?

Aclarion Inc has a market cap of about $0.01B.

What does Aclarion Inc (ACON) do?

Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinic